Seeking Alpha

Inovio nabs $4.6M in NIH funding for antimicrobial resistance research

|About: Inovio Pharmaceuticals... (INO)|By:, SA News Editor

The National Institutes of Health (NIH) awards a $4.6M grant to Inovio Pharmaceuticals (INO -2.2%) to support research in antimicrobial resistance using its DNA-encoded monoclonal antibodies (dMAb) platform.

The grant will fund additional preclinical studies with the ultimate goal of launching clinical trials evaluating dMAbs for antimicrobial-resistant infections.

Subscribe for full text news in your inbox